Loading...

Fixation Buffer

Pricing & Availability
Regulatory Status
RUO
Other Names
Fixative, Paraformaldehyde
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420801 100 mL 48€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Fixation Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Fixation Buffer is used to fix cells prior to permeabilization using Permeabilization Wash Buffer (Cat. No. 421002). BioLegend's Fixation Buffer has been formulated with prescreened paraformaldehyde with low background, thus producing the greatest signal to noise ratio.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
This buffer solution should be stored between 2°C and 8°C.
Application

ICFC - Quality tested
ICC
Recommended Usage

For cell fixation, use 250 µL fixation buffer per tube and leave it in the dark for 20 minutes at room temperature. It is recommended that the reagent be titrated for optimal performance for each application. For the fixation procedure, please refer to the "Intracellular Cytokine Staining Protocol" under "Support" on BioLegend's website.
Caution: This buffer contains paraformaldehyde, which is toxigenic and mutagenic. Please handle with caution and wear gloves, lab coat and necessary protection to avoid direct body contacts.

Application Notes

This 1X PBS solution contains 4% paraformaldehyde, which is toxic and is a suspected carcinogen. Contact with eyes, skin and mucous membranes should be avoided.

Additional Product Notes

View more applications data using this product to stain Veri-Cells™ lyophilized control cells and to perform phospho-flow in our Scientific Poster Library.

Application References
  1. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  2. Kenna TJ, et al. 2010. J. Immunol. 184:598. PubMed
  3. Sullivan BP, et al. 2010. Am J Pathol. 177:2837. PubMed
  4. del Rio ML, et al. 2011.Transplantation. 92:1085. PubMed
  5. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  6. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  7. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  8. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
Product Citations
  1. Shen Z, et al. 2020. Bioact Mater. 5:1113. PubMed
  2. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  3. Stoycheva D, et al. 2021. Eur J Immunol. 51:1423. PubMed
  4. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  5. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  6. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  7. Madi A, et al. 2022. Int J Cancer. 151:797. PubMed
  8. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  9. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  10. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  11. Chen ML, et al. 2022. Mol Cancer Ther. 21:1337. PubMed
  12. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  13. Gutierrez WR, et al. 2022. JCI Insight. 7: . PubMed
  14. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  15. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  16. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  17. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  18. Noh J, et al. 2022. Cancers (Basel). 14: . PubMed
  19. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  20. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  21. Chan L, et al. 2022. Cells. 12: . PubMed
  22. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  23. Gong HH, et al. 2023. Front Immunol. 13:1089064. PubMed
  24. Teplensky MH, et al. 2023. Nat Biomed Eng. :. PubMed
  25. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  26. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  27. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  28. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  29. Zander R, et al. 2022. Immunity. 55:475. PubMed
  30. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  31. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  32. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  33. Tipanee J, et al. 2022. Mol Ther. 30:3155. PubMed
  34. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  35. de Groot AE, et al. 2022. Neoplasia. 32:100830. PubMed
  36. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  37. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  38. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  39. Chernozem RV, et al. 2023. Adv Healthc Mater. 12:e2201726. PubMed
  40. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  41. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  42. Humphries DC, et al. 2023. Front Immunol. 14:1100161. PubMed
  43. Wang H, et al. 2023. Nature. 615:339. PubMed
  44. Gayet RV, et al. 2023. Nat Commun. 14:1339. PubMed
  45. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  46. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  47. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  48. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  49. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  50. Amirova KM, et al. 2023. Int J Mol Sci. 24:. PubMed
  51. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  52. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  53. Shou J, et al. 2023. Sci Adv. 9:eade9118. PubMed
  54. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  55. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  56. Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed
  57. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  58. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  59. Salybekov AA, et al. 2018. PLoS One. 13:e0203244. PubMed
  60. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  61. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  62. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  63. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  64. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  65. Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed
  66. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  67. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  68. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  69. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  70. Ede J, et al. 2015. Toxicol Sci. 148: 108 - 120. PubMed
  71. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  72. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  73. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  74. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  75. Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed
  76. Garton J, et al. 2021. Immunohorizons. 5:802. PubMed
  77. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  78. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  79. Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed
  80. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
  81. Kuo T, et al. 2017. Oncogene. 10.1038/onc.2017.156. PubMed
  82. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
  83. Bawazir M, et al. 2022. Front Immunol. 13:1033794. PubMed
  84. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  85. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  86. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  87. Brooks JF, et al. 2020. J Immunol. 205:1239. PubMed
  88. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  89. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  90. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  91. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  92. Wright A, et al. 2015. Immunobiology. 220: 859-864. PubMed
  93. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  94. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  95. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  96. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  97. Bayer AL, et al. 2022. Cancers (Basel). 14:. PubMed
  98. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  99. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  100. Guye P, et al. 2016. Nat Commun. 7:10243. PubMed
  101. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  102. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  103. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  104. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  105. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  106. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  107. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  108. Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed
  109. Klepsch V, et al. 2020. Cell Commun Signal. 18:08. PubMed
  110. Sullivan B, et al. 2010. Am J Pathol. 177:2837. PubMed
  111. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  112. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
  113. Callahan SM, et al. 2021. Curr Protoc. 1:e294. PubMed
  114. Huang M, et al. 2022. Adv Sci (Weinh). 9:e2101267. PubMed
  115. Takahashi K, et al. 2022. Cell Rep Methods. 2:100155. PubMed
  116. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  117. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  118. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  119. Rada M, et al. 2021. Commun Biol. 4:950. PubMed
  120. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  121. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  122. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  123. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
  124. Cho S, et al. 2017. Sci Rep. 7:35. PubMed
  125. Callahan S, et al. 2020. Cell Microbiol. 22:e13210. PubMed
  126. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  127. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
  128. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  129. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  130. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  131. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  132. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  133. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  134. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  135. Lamb C, et al. 2016. J Crohns Colitis. 10.1093/ecco-jcc/jjw189. PubMed
  136. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  137. Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
  138. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  139. Hornigold K, et al. 2022. Front Immunol. 13:888415. PubMed
  140. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  141. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  142. Bekeschus S, et al. 2016. J Leukoc Biol. 100: 791 - 799. PubMed
  143. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  144. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  145. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  146. Willis RA, et al. 2021. Curr Protoc. 1:e36. PubMed
  147. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  148. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  149. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  150. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  151. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  152. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  153. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  154. Dominguez CX, et al. 2020. Cancer Discov. 0.577777778. PubMed
  155. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  156. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  157. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  158. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  159. Ma K, et al. 2022. iScience. 25:104347. PubMed
  160. Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed
  161. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  162. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  163. Kenna T, et al. 2010. J Immunol. 184:598. PubMed
  164. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  165. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  166. Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed
  167. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  168. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  169. Bruno MEC, et al. 2022. Geroscience. 44:1761. PubMed
  170. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  171. Yokota-Nakatsuma A, et al. 2016. Sci Rep. 6:37914. PubMed
  172. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  173. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  174. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  175. Gerson-Gurwitz A, et al. 2021. Front Oncol. 11:766298. PubMed
  176. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  177. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  178. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  179. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  180. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  181. Glaser K, et al. 2016. PLoS One. 11: 0146898. PubMed
  182. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  183. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  184. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  185. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  186. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  187. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  188. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  189. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  190. Kissel T, et al. 2022. Sci Adv. 8:eabm1759. PubMed
  191. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  192. Haunerdinger V, et al. 2021. Front Immunol. 12:740047. PubMed
  193. Gensterblum E,et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.09.011. PubMed
  194. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  195. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  196. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  197. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  198. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  199. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  200. Wang X, et al. 2022. Elife. 11:. PubMed
  201. Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed
  202. Nouraei N,et al. 2017. Exp Neurol.. 10.1016/j.expneurol.2017.10.017. PubMed
  203. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  204. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  205. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  206. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  207. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  208. Melcher M, et al. 2017. Stem Cell Res Ther . 10.1186/s13287-017-0601-7. PubMed
  209. Clancy-Thompson E, et al. 2015. Cancer Immunol Res. 3: 956-967. PubMed
  210. Wang L, et al. 2016. Oncogene. 10.1038/onc.2016.380. PubMed
  211. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  212. Yoshikawa AM, et al. 2021. Nat Commun. 12:7106. PubMed
  213. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  214. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  215. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 4    Revision Date: 07/25/2022

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account